519 related articles for article (PubMed ID: 18661511)
1. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
[TBL] [Abstract][Full Text] [Related]
2. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
3. The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study.
Piaścik M; Rydzewska G; Milewski J; Olszewski S; Furmanek M; Walecki J; Gabryelewicz A
Pancreas; 2010 Aug; 39(6):863-7. PubMed ID: 20431422
[TBL] [Abstract][Full Text] [Related]
4. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.
Takeda K; Matsuno S; Sunamura M; Kakugawa Y
Am J Surg; 1996 Apr; 171(4):394-8. PubMed ID: 8604829
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
6. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
7. [A case of ALL complicated with acute pancreatitis and pancreatic pseudocyst caused by L-asparaginase ].
Yasui I; Shimokawa T; Kasai M; Yamada H; Watanabe E; Takeyama H; Satake T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):149-52. PubMed ID: 8422180
[TBL] [Abstract][Full Text] [Related]
8. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of continuous arterial infusion of the protease inhibitor and the antibiotics and via celiac and superior mesenteric artery for severe acute pancreatitis--pilot study.
Ishikawa T; Imai M; Kamimura H; Ushiki T; Tsuchiya A; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T
Hepatogastroenterology; 2009; 56(90):524-8. PubMed ID: 19579635
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
11. New strategy for acute necrotizing pancreatitis: Continuous Regional Arterial Infusion (CRAI) therapy.
Mikami Y; Takeda K; Omura N; Abe H; Fukuyama S; Motoi F; Egawa S; Sunamura M; Matsuno S
Rocz Akad Med Bialymst; 2005; 50():101-5. PubMed ID: 16358947
[TBL] [Abstract][Full Text] [Related]
12. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
[TBL] [Abstract][Full Text] [Related]
13. Blood lipid profiles in children with acute lymphoblastic leukemia.
Halton JM; Nazir DJ; McQueen MJ; Barr RD
Cancer; 1998 Jul; 83(2):379-84. PubMed ID: 9669823
[TBL] [Abstract][Full Text] [Related]
14. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit.
Imaizumi H; Kida M; Nishimaki H; Okuno J; Kataoka Y; Kida Y; Soma K; Saigenji K
Pancreas; 2004 May; 28(4):369-73. PubMed ID: 15097852
[TBL] [Abstract][Full Text] [Related]
16. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy.
Treepongkaruna S; Thongpak N; Pakakasama S; Pienvichit P; Sirachainan N; Hongeng S
J Pediatr Hematol Oncol; 2009 Nov; 31(11):812-5. PubMed ID: 19801948
[TBL] [Abstract][Full Text] [Related]
17. [Long-term infusion of L-asparaginase--an alternative to intramuscular injection?].
Rodriguez T; Baumgarten E; Fengler R; Soumpasis D; Henze G
Klin Padiatr; 1995; 207(4):207-10. PubMed ID: 7564153
[TBL] [Abstract][Full Text] [Related]
18. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Earl M
Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
[TBL] [Abstract][Full Text] [Related]
19. A desensitization protocol in children with L-asparaginase hypersensitivity.
Akbayram S; Doğan M; Akgün C; Caksen H; Oner AF
J Pediatr Hematol Oncol; 2010 Jul; 32(5):e187-91. PubMed ID: 20505537
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
